Current Journal of Neurology

Mohammadreza Jamshidi; Milad Abbasian; Ali Ghasemnezhad; Atoosa Keshavarz-Motamed; Zehra Batool; Arian Tavasol; Mahsa Nikfarjam; Mohammad Moein Ashrafi; Atefeh Zare-Ahmadabadi; Seyyed Ali Jalalian

Volume 23, Issue 3, July 2024, Pages 176-189

https://doi.org/http://dx.doi.org/10.18502/cjn.v23i3.17601

Investigation of pregnancy tendency, reproductive characteristics, and disability in women with multiple sclerosis: A secondary data analysis of the national registry in Iran

Sajjad Ghane Ezabadi; Fereshteh Ashtari; Seyed Mohammad Baghbanian; Nastaran Majdi-Nasab; Elham Madreseh; Hamidreza Hatamian; Fardin Faraji; Asghar Bayati; Hoda Kamali; Ehsan Sharifipour; Hossein Mozhdehipanah; Mohammad Amin Shahrbaf; Saeideh Ayoubi; Mohammad Ali Sahraian; Sharareh Eskandarieh

Volume 23, Issue 2, April 2024, Pages 106-116

https://doi.org/http://dx.doi.org/10.18502/cjn.v23i2.16839

New diagnosis of multiple sclerosis in the setting of recent Sinopharm COVID-19 vaccine (BBIBP-CorV) exposure: A series of clinical cases and updated review of the literature

Sepideh Paybast; Melika Jameie; Mojtaba Shahbazi; Mohammad Amin Habibi; Seyed Ehsan Mohammadianinejad; Mohammad Hossein Harirchian

Volume 23, Issue 1, January 2024, Pages 21-38

https://doi.org/10.18502/cjn.v23i1.16430

Psychometric validation of the Persian version of the CarerQol-7D instrument on caregivers of patients with multiple sclerosis

Hoda Faraji; Isa Akbarzadeh; Mehdi Yaseri; Mohammad Ali Sahraian; Shekoufeh Nikfar

Volume 23, Issue 1, January 2024, Pages 59-65

https://doi.org/10.18502/cjn.v23i1.16433

Evaluation of obsessive-compulsive disorder prevalence in Iranian patients with multiple sclerosis and its relationship with demographic characteristics

Ali Keyhani; Mohammad Javad Shabani; Farnaz Etesam; Nasim Rezaeimanesh; Amirreza Azimi; Abdorreza Naser Moghadasi

Volume 22, Issue 4, October 2023, Pages 204-209

https://doi.org/10.18502/cjn.v22i4.14523

Social support and anxiety correlation with resilience in patients with multiple sclerosis during COVID-19 pandemic

Vahid Shaygannejad; Omid Mirmosayyeb; Aysa Shaygannejad; Saeed Vaheb; Sara Bagherieh; Mozhdeh Askari; Mahsa Ghajarzadeh

Volume 22, Issue 4, October 2023, Pages 217-220

https://doi.org/10.18502/cjn.v22i4.14525

The effect of atomoxetine on cognitive function in patients with multiple sclerosis

Ehsan Mohammadian Nejad; Effat Amouzadeh; Davood Kashipazha; Gholamreza Shamsaei; Bahman Cheraghian

Volume 22, Issue 3, July 2023, Pages 149-154

https://doi.org/10.18502/cjn.v22i3.13792

Factors associated with the number of months of delaying in multiple sclerosis diagnosis: Comparison of count regression models

Abolfazl Hosseinnataj; Roya Nikbakht; Seyed Nouraddin Mousavinasab; Sharareh Eskandarieh; Mohammad Ali Sahraian; Seyed Mohammad Baghbanian

Volume 22, Issue 2, April 2023, Pages 65-71

https://doi.org/10.18502/cjn.v22i2.13330

Fear of re-infection, relapse, and anxiety during COVID-19 pandemic in patients with multiple sclerosis: A multi-center study

Abdorreza Naser Moghadasi; Saeed Vaheb; Sara Hamtaei-Ghashti; Aysa Shaygannejad; Mozhdeh Askari; Vahid Shaygannejad; Mohmmad Ali Sahraian; Mahsa Ghajarzadeh

Volume 22, Issue 2, April 2023, Pages 82-86

https://doi.org/10.18502/cjn.v22i2.13332

Iranian specialists’ approach to surgery in patients with multiple sclerosis

Fereshteh Ghadiri; Zahra Ebadi; Elnaz Asadollahzadeh; Mohammad Ali Sahraian; Amirreza Azimi; Samira Navardi; Hora Heidari; Zohreh Abna; Marzieh Aboutorabi; Iman Adibi; Seyed Mohammad Baghbanian; Sepideh Paybast; Maryam Poursadeghfard; Samaneh Hosseini; Sareh Shahmohammadi; Mehran Ghaffari; Hamidreza Ghalyanchi-Langroodi; Masoud Ghiasian; Hoda Kamali; Ebrahim Kouchaki; Farzad Mehrabi; Ehsan Mohammadianinejad; Mohammad Ali Nahayati; Abdorreza Naser Moghadasi

Volume 22, Issue 2, April 2023, Pages 96-102

https://doi.org/10.18502/cjn.v22i2.13336

Epidemiological parameters of multiple sclerosis in Chaharmahal and Bakhtiari Province, Iran

Mohammad Amin Omrani; Asghar Bayati; Mohammad Ali Sahraian; Sharareh Eskandarieh

Volume 22, Issue 2, April 2023, Pages 103-109

https://doi.org/10.18502/cjn.v22i2.13337

Alternate dosing of fingolimod in relapsing-remitting multiple sclerosis: A systematic review

Fereshteh Ghadiri; Omid Mirmosayyeb; Mohammad Ali Sahraian; Abdorreza Naser Moghadasi; Mahsa Ghajarzadeh

Volume 22, Issue 2, April 2023, Pages 110-114

https://doi.org/10.18502/cjn.v22i2.13339

Adverse side effects of Glatiramer acetate and Interferon beta-1a in patients with multiple sclerosis: A systematic review of case reports

Mohsen Rastkar; Mahsa Ghajarzadeh; Mohammad Ali Sahraian

Volume 22, Issue 2, April 2023, Pages 115-136

https://doi.org/10.18502/cjn.v22i2.13340

Iranian specialists’ approach to treatment escalation in multiple sclerosis patients with cognitive impairment

Fereshteh Ghadiri; Elnaz Asadollahzadeh; Zahra Ebadi; Mohammad Ali Sahraian; Amirreza Azimi; Samira Navardi; Hora Heidari; Zohreh Abna; Marzieh Aboutorabi; Iman Adibi; Seyed Mohammad Baghbanian; Sepideh Paybast; Maryam Poursadeghfard; Samaneh Hosseini; Sareh Shahmohammadi; Mehran Ghaffari; Hamidreza Ghalyanchi-Langroodi; Masoud Ghiasian; Hoda Kamali; Ebrahim Kouchaki; Farzad Mehrabi; Ehsan Mohammadianinejad; Mohammad Ali Nahayati; Abdorreza Naser Moghadasi

Volume 22, Issue 1, January 2023, Pages 1-7

https://doi.org/10.18502/cjn.v22i1.12610